Education
About Us
Working with TipRanks
Follow Us
Richard Chin Insider Profile
4 Followers
Richard Chin, CEO, Director at Kindred Biosciences, holds 1.53M shares in Kindred Biosciences (Ticker: KIN), holds 0.00 shares in SELLAS Life Sciences Group (Ticker: SLS), holds 392.07K shares in Oncotelic Therapeutics (Ticker: OTLC).
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+65.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Richard Chin holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jan 31, 2014 - Jan 31, 2015
Return:+69.00%
The most profitable trade made by Richard Chin
Richard Chin's Trading History
Kindred Biosciences
Aug 04, 2021
―
Uninformative Sell
368.00K
$14.19M
SELLAS Life Sciences Group
Oct 10, 2017
Director
Uninformative Buy
4.83K
$0.00
Oncotelic Therapeutics
―
President & CEO, Director
―
$15.68K
ImmunoCellular Therapeutics
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Richard Chin's performance on stock
You May Also Like
Richard Chin insider profile FAQ
What is the percentage of profitable transactions made by Richard Chin?
The percentage of profitable transactions made by Richard Chin is 100%.
What is the average return per transaction made by Richard Chin?
The average return per transaction made by Richard Chin is 65.20%.
What stocks does Richard Chin hold?
Richard Chin holds: KIN, SLS, OTLC, IMUC stocks.
What was Richard Chin’s latest transaction?
Richard Chin latest transaction was an Uninformative Sell of $368.00K.
What was Richard Chin's most profitable transaction?
Richard Chin’s most profitable transaction was an Informative Sell of SLS stock on January 31, 2014. The return on the trade was 69.00%.
What is Richard Chin's role in Kindred Biosciences?
Richard Chin's role in Kindred Biosciences is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.